Suppr超能文献

[腹膜透析在终末期慢性肾功能不全治疗中的作用。患者生存率及方法]

[Role of peritoneal dialysis in the treatment of terminal chronic renal insufficiency. Survival of patients and method].

作者信息

Ryckelynck J P, Hurault de Ligny B, Levaltier B, Cardineau E, Le Goff C, Batho J M

机构信息

Service de néphrologie-hémodialyse, Centre hospitalier universitaire Clémenceau, Caen.

出版信息

Nephrologie. 1995;16(1):85-92.

PMID:7700425
Abstract

Chronic peritoneal dialysis, especially continuous ambulatory peritoneal dialysis, is now a modality of treatment for patients with end stage renal failure. The proportion of patients varies considerably from country to country. Non medical considerations seem to be the main reason for the limited development of the treatment modality. Most of available reports point out no difference in patient or technique survivals on hemodialysis or peritoneal dialysis. Age, diabetes mellitus, cardiovascular diseases, infections complications (peritonitis and exit-site infections) impact on mortality and morbidity (number of hospital days per patient per year). The probability of death or dropout is much higher for patients with diabetes and patients in older age groups. Most patients with end stage renal failure, especially those waiting for a kidney transplant, are suitable for peritoneal dialysis.

摘要

慢性腹膜透析,尤其是持续性非卧床腹膜透析,现已成为终末期肾衰竭患者的一种治疗方式。各国接受该治疗方式的患者比例差异很大。非医学因素似乎是该治疗方式发展受限的主要原因。大多数现有报告指出,血液透析和腹膜透析在患者生存率或技术生存率方面并无差异。年龄、糖尿病、心血管疾病、感染并发症(腹膜炎和出口处感染)会影响死亡率和发病率(每年每位患者的住院天数)。糖尿病患者和老年患者死亡或退出治疗的可能性要高得多。大多数终末期肾衰竭患者,尤其是那些等待肾移植的患者,适合进行腹膜透析。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验